Quantitative approaches to drug development
Quantitative approaches to drug development
We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives. Science and Services
About
Pharmetheus reduces uncertainty in all phases of drug development.
News
The tutorial titled “Full Random Effects Models (FREM): A Practical Usage Guide” delves into the innovative FREM methodology, a robust complement to traditional covariate modeling techniques. We believe this tutorial is a valuable resource for researchers and practitioners in the field of pharmacometrics, offering insights into the application of FREM to improve learnings from the analyses of clinical trial data,…
Dr. Anna Mc Laughlin has dedicated her efforts within oncology to model-based treatment optimization of targeted anti-cancer therapies, including CAR-T cells (Chimeric Antigen Receptor T cells), anti-hormonal drugs, and tyrosine kinase inhibitors. – There has been a remarkable success of CAR-T cell therapy in treating aggressive hematological malignancies such as lymphoma. Though it’s is not just limited to blood cancers…
Focusing on breaking linguistic barriers, the non-profit organization Pharmacometrics Africa, with support from Pharmetheus and French-speaking faculty professors, launched a French version of their online course in Clinical Pharmacology and Pharmacometrics. The program is tailored for French-speaking scientists within and from Africa and spans 3 months. – Learning material in French opens doors for developing the scientific competencies within french-speaking…
Science & Services
How we work
Traceability, accountability, and independent quality control are of utmost importance to us, and embedded in our way of working.
Publications
Explore our scientific publications.
Explore our web
Model Informed Drug Development
A quantitative framework to support and inform development program strategies and decisions.
“Sharing with colleagues is why I love working here”
Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.
History of Pharmetheus
Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.